{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:05:39Z","timestamp":1789020339424,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s13346-025-02011-7","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T19:34:17Z","timestamp":1762976057000},"page":"1136-1163","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development, in silico, in vitro, and in vivo evaluation of gatiserts: HME-based ophthalmic inserts for prolonged ocular delivery of gatifloxacin"],"prefix":"10.1007","volume":"16","author":[{"given":"Amit","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh Kumar","family":"Behera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jourawar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayesh","family":"Beladiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devang","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhwani","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapan","family":"Borah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aakanchha","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3527-9158","authenticated-orcid":false,"given":"Derajram","family":"Benival","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"2011_CR1","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1001\/jama.2013.280318","volume":"310","author":"AA Azari","year":"2013","unstructured":"Azari AA, Barney NP, Conjunctivitis. A systematic review of diagnosis and treatment. JAMA. 2013;310:1721\u20139.","journal-title":"JAMA"},{"key":"2011_CR2","doi-asserted-by":"crossref","unstructured":"H\u00f8vding G. Acute bacterial conjunctivitis. Acta Ophthalmol. 2008;86:5\u201317. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/17970823\/","DOI":"10.1111\/j.1600-0420.2007.01006.x"},{"key":"2011_CR3","doi-asserted-by":"crossref","unstructured":"Sheikh A, Hurwitz B. Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst Rev. 2006; Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/16625540\/","DOI":"10.1002\/14651858.CD001211.pub2"},{"key":"2011_CR4","doi-asserted-by":"crossref","unstructured":"Sheikh A, Hurwitz B, Cave J. Antibiotics for acute bacterial conjunctivitis. Cochrane Database Syst Rev. 2000;CD001211. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10796757","DOI":"10.1002\/14651858.CD001211"},{"key":"2011_CR5","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S0002-9394(03)00294-0","volume":"136","author":"RP Kowalski","year":"2003","unstructured":"Kowalski RP, Dhaliwal DK, Karenchak LM, Romanowski EG, Mah FS, Ritterband DC, et al. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and Ofloxacin using bacterial keratitis isolates. Am J Ophthalmol. 2003;136:500\u20135.","journal-title":"Am J Ophthalmol"},{"key":"2011_CR6","doi-asserted-by":"crossref","unstructured":"Alfonso E, Crider J. Ophthalmic infections and their anti-infective challenges. Surv Ophthalmol. 2005;50 Suppl 1. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/16257307\/","DOI":"10.1016\/j.survophthal.2005.05.001"},{"key":"2011_CR7","doi-asserted-by":"crossref","unstructured":"Hwang DG. Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. Surv Ophthalmol. 2004;49. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/15028483\/","DOI":"10.1016\/j.survophthal.2004.01.004"},{"key":"2011_CR8","unstructured":"Drug Approval Package: Zymar (Gatifloxacin) NDA #021493. 2003. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2003\/021493_Zymar.cfm"},{"key":"2011_CR9","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","volume":"58","author":"A Urtti","year":"2006","unstructured":"Urtti A. Challenges and Obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev. 2006;58:1131\u20135.","journal-title":"Adv Drug Deliv Rev"},{"key":"2011_CR10","doi-asserted-by":"publisher","unstructured":"Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular Drug Delivery. The AAPS Journal 2010 12:3. 2010;12:348\u201360. Available from: https:\/\/link.springer.com\/article\/https:\/\/doi.org\/10.1208\/s12248-010-9183-3","DOI":"10.1208\/s12248-010-9183-3"},{"key":"2011_CR11","doi-asserted-by":"crossref","unstructured":"Putterman AM. Instilling ocular ointments without blurred vision. Arch Ophthalmol. 1985;103:1276. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/4038111\/","DOI":"10.1001\/archopht.1985.01050090026011"},{"key":"2011_CR12","doi-asserted-by":"crossref","unstructured":"Smolle M, Keller C, Pinggera G, Deibl M, Rieder J, Lirk P. Clear hydro-gel, compared to ointment, provides improved eye comfort after brief surgery. Can J Anaesth. 2004;51:126\u20139. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/14766687\/","DOI":"10.1007\/BF03018770"},{"key":"2011_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0169-409X(95)00014-X","volume":"16","author":"MF Saettone","year":"1995","unstructured":"Saettone MF, Salminen L. Ocular inserts for topical delivery. Adv Drug Deliv Rev. 1995;16:95\u2013106.","journal-title":"Adv Drug Deliv Rev"},{"key":"2011_CR14","doi-asserted-by":"crossref","unstructured":"Kumari A, Sharma PK, Garg VK, Garg G. Ocular inserts - Advancement in therapy of eye diseases. J Adv Pharm Technol Res. 2010;1:291\u20136. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22247860\/","DOI":"10.4103\/0110-5558.72419"},{"key":"2011_CR15","unstructured":"Khan A, Raza SN, Itoo A, Bashir S, Wani TU, Khan NA, OCULAR, INSERTS - A, NOVEL APPROACH IN OCULAR DRUG DELIVERY. Journal of Drug Delivery and Therapeutics. 2019;9:693\u2013703. Available from: https:\/\/jddtonline.info\/index.php\/jddt\/article\/view\/3207"},{"key":"2011_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2478\/v10007-012-0002-5","volume":"62","author":"PK Pawar","year":"2012","unstructured":"Pawar PK, Katara R, Majumdar D. Design and evaluation of Moxifloxacin hydrochloride ocular inserts. Acta Pharm. 2012;62:93\u2013104.","journal-title":"Acta Pharm"},{"key":"2011_CR17","doi-asserted-by":"crossref","unstructured":"Pawar P, Khurana G, Arora S. Ocular insert for sustained delivery of gatifloxacin sesquihydrate: Preparation and evaluations. Int J Pharm Investig. 2012;2:70. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23119235\/","DOI":"10.4103\/2230-973X.100040"},{"key":"2011_CR18","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1016\/j.xphs.2017.07.017","volume":"106","author":"S Prachetan Balguri","year":"2017","unstructured":"Prachetan Balguri S, Adelli GR, Tatke A, Yadav Janga K, Bhagav P, Majumdar S. Melt-Cast noninvasive ocular inserts for posterior segment drug delivery HHS public access. J Pharm Sci. 2017;106:3515\u201323.","journal-title":"J Pharm Sci"},{"key":"2011_CR19","doi-asserted-by":"publisher","unstructured":"Patil H, Tiwari RV, Repka MA. Hot-Melt Extrusion: from Theory to Application in Pharmaceutical Formulation. AAPS PharmSciTech. 2016;17:20\u201342. Available from: https:\/\/link.springer.com\/article\/https:\/\/doi.org\/10.1208\/s12249-015-0360-7","DOI":"10.1208\/s12249-015-0360-7"},{"key":"2011_CR20","doi-asserted-by":"crossref","unstructured":"Repka MA, Battu SK, Upadhye SB, Thumma S, Crowley MM, Zhang F et al. Pharmaceutical applications of hot-melt extrusion: Part II. Drug Dev Ind Pharm. 2007;33:1043\u201357. Available from: https:\/\/www.tandfonline.com\/action\/journalInformation?journalCode=iddi20","DOI":"10.1080\/03639040701525627"},{"key":"2011_CR21","doi-asserted-by":"crossref","unstructured":"Crowley MM, Zhang F, Repka MA, Thumma S, Upadhye SB, Battu SK et al. Pharmaceutical applications of hot-melt extrusion: Part I. Drug Dev Ind Pharm. 2007;33:909\u201326. Available from: https:\/\/www.tandfonline.com\/action\/journalInformation?journalCode=iddi20","DOI":"10.1080\/03639040701498759"},{"key":"2011_CR22","doi-asserted-by":"crossref","unstructured":"Thakkar R, Komanduri N, Dudhipala N, Tripathi S, Repka MA, Majumdar S. Development and optimization of hot-melt extruded Moxifloxacin hydrochloride inserts, for ocular applications, using the design of experiments. Int J Pharm. 2021;603.","DOI":"10.1016\/j.ijpharm.2021.120676"},{"key":"2011_CR23","doi-asserted-by":"crossref","unstructured":"Alzahrani A, Adel Ali Youssef A, Senapati S, Tripathi S, Bandari S, Majumdar S et al. Formulation development and in Vitro\u2013Ex vivo characterization of hot-melt extruded Ciprofloxacin hydrochloride inserts for ocular applications: part I. Int J Pharm. 2023;630.","DOI":"10.1016\/j.ijpharm.2022.122423"},{"key":"2011_CR24","unstructured":"Lacrisert \u00ae (Hydroxypropyl Cellulose Ophthalmic Insert). 1981. Available from: https:\/\/www.fda.gov\/drugsatfda"},{"key":"2011_CR25","unstructured":"Fisher Scientific T. Thermo Scientific HAAKE MiniCTW. 2022. Available from: https:\/\/www.thermofisher.com\/order\/catalog\/product\/567-2090"},{"key":"2011_CR26","unstructured":"Fisher Scientific T. Product specifications Thermo Scientific CaliCut Post-extrusion System. 2019. Available from: https:\/\/assets.thermofisher.com\/TFS-Assets\/MSD\/Technical-Notes\/TN623-4005-CaliCut-post-extrusion-system.pdf"},{"key":"2011_CR27","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.xphs.2023.12.015","volume":"113","author":"D Rana","year":"2024","unstructured":"Rana D, Beladiya J, Sheth D, Salave S, Sharma A, Jindal AB, et al. Precise fabrication of ocular inserts using an innovative Laser-Driven CaliCut technology: in vitro and in vivo evaluation. J Pharm Sci. 2024;113:1339\u201350.","journal-title":"J Pharm Sci"},{"key":"2011_CR28","doi-asserted-by":"publisher","first-page":"124783","DOI":"10.1016\/j.ijpharm.2024.124783","volume":"666","author":"D Rana","year":"2024","unstructured":"Rana D, Beladiya J, Sheth D, Kumar H, Jindal AB, Shah G, et al. Investigating a novel therapeutic composition for dry eye syndrome management: in vitro and in vivo studies. Int J Pharm. 2024;666:124783.","journal-title":"Int J Pharm"},{"key":"2011_CR29","doi-asserted-by":"crossref","unstructured":"UniProt Consortium. Reorganizing the protein space at the Universal Protein Resource (UniProt). Nucleic Acids Res. 2012;40:D71-5. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22102590","DOI":"10.1093\/nar\/gkr981"},{"key":"2011_CR30","doi-asserted-by":"publisher","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H et al. The Protein Data Bank. Nucleic Acids Res. 2000;28:235\u201342. Available from: https:\/\/doi.org\/10.1093\/nar\/28.1.235","DOI":"10.1093\/nar\/28.1.235"},{"key":"2011_CR31","doi-asserted-by":"publisher","unstructured":"Burley SK, Bhatt R, Bhikadiya C, Bi C, Biester A, Biswas P et al. Updated resources for exploring experimentally-determined PDB structures and Computed Structure Models at the RCSB Protein Data Bank. Nucleic Acids Res. 2025;53:D564\u201374. Available from: https:\/\/doi.org\/10.1093\/nar\/gkae1091","DOI":"10.1093\/nar\/gkae1091"},{"key":"2011_CR32","doi-asserted-by":"crossref","unstructured":"Roche DB, Buenavista MT, Tetchner SJ, McGuffin LJ. The IntFOLD server: an integrated web resource for protein fold recognition, 3D model quality assessment, intrinsic disorder prediction, domain prediction and ligand binding site prediction. Nucleic Acids Res. 2011;39. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21459847\/","DOI":"10.1093\/nar\/gkr184"},{"key":"2011_CR33","doi-asserted-by":"crossref","unstructured":"Govindarajan B, Gipson IK. Membrane-tethered mucins have multiple functions on the ocular surface. Exp Eye Res. 2010;90:655\u201363. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0014483510000734","DOI":"10.1016\/j.exer.2010.02.014"},{"key":"2011_CR34","doi-asserted-by":"crossref","unstructured":"Ruponen M, Urtti A. Undefined role of mucus as a barrier in ocular drug delivery. European Journal of Pharmaceutics and Biopharmaceutics. 2015;96:442\u20136. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0939641115001411","DOI":"10.1016\/j.ejpb.2015.02.032"},{"key":"2011_CR35","doi-asserted-by":"crossref","unstructured":"Blalock TD, Spurr-Michaud SJ, Tisdale AS, Gipson IK. Release of Membrane-associated Mucins from Ocular Surface Epithelia. Invest Ophthalmol Vis Sci. 2008;49:1864. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2622730\/","DOI":"10.1167\/iovs.07-1081"},{"key":"2011_CR36","doi-asserted-by":"crossref","unstructured":"Kawabata T. Detection of multiscale pockets on protein surfaces using mathematical morphology. Proteins. 2010;78:1195\u2013211. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19938154\/","DOI":"10.1002\/prot.22639"},{"key":"2011_CR37","doi-asserted-by":"crossref","unstructured":"Tian W, Chen C, Liang J. CASTp 3.0: Computed Atlas of Surface Topography of Proteins and Beyond. Biophys J. 2018;114:50a. Available from: http:\/\/www.cell.com\/article\/S0006349517315576\/fulltext","DOI":"10.1016\/j.bpj.2017.11.325"},{"key":"2011_CR38","unstructured":"DEPTH IISER Pune. 2013. Available from: http:\/\/cospi.iiserpune.ac.in\/depth\/"},{"key":"2011_CR39","doi-asserted-by":"publisher","unstructured":"Tan KP, Nguyen TB, Patel S, Varadarajan R, Madhusudhan MS. Depth: a web server to compute depth, cavity sizes, detect potential small-molecule ligand-binding cavities and predict the pKa of ionizable residues in proteins. Nucleic Acids Res. 2013;41:W314\u201321. Available from: https:\/\/doi.org\/10.1093\/nar\/gkt503","DOI":"10.1093\/nar\/gkt503"},{"key":"2011_CR40","doi-asserted-by":"publisher","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S et al. PubChem in 2021: new data content and improved web interfaces. Nucleic Acids Res. 2021;49:D1388\u201395. Available from: https:\/\/doi.org\/10.1093\/nar\/gkaa971","DOI":"10.1093\/nar\/gkaa971"},{"key":"2011_CR41","doi-asserted-by":"publisher","first-page":"123579","DOI":"10.1016\/j.ijpharm.2023.123579","volume":"648","author":"S Tambe","year":"2023","unstructured":"Tambe S, Jain D, Rawat R, Mali S, Pagano MA, Brunati AM, et al. MeltSerts technology (brinzolamide ocular inserts via hot-melt extrusion): QbD-steered development, molecular dynamics, in vitro, ex vivo and in vivo studies. Int J Pharm. 2023;648:123579.","journal-title":"Int J Pharm"},{"key":"2011_CR42","doi-asserted-by":"crossref","unstructured":"Ludwig A. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev. 2005;57:1595\u2013639. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/16198021\/","DOI":"10.1016\/j.addr.2005.07.005"},{"key":"2011_CR43","doi-asserted-by":"publisher","unstructured":"Vyas S, Khambete M, Gudhka R, Panchamia S, Degani M, Patravale V. In silico modeling of functionalized poly(methylvinyl ether\/maleic acid) for controlled drug release in the ocular milieu. Drug Deliv Transl Res. 2020;10:1085\u201394. Available from: https:\/\/link.springer.com\/article\/https:\/\/doi.org\/10.1007\/s13346-020-00749-w","DOI":"10.1007\/s13346-020-00749-w"},{"key":"2011_CR44","doi-asserted-by":"crossref","unstructured":"Durrant JD, McCammon JA. Molecular dynamics simulations and drug discovery. BMC Biol. 2011;9. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22035460\/","DOI":"10.1186\/1741-7007-9-71"},{"key":"2011_CR45","doi-asserted-by":"crossref","unstructured":"Shivakumar D, Williams J, Wu Y, Damm W, Shelley J, Sherman W. Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field. J Chem Theory Comput. 2010;6:1509\u201319. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26615687\/","DOI":"10.1021\/ct900587b"},{"key":"2011_CR46","doi-asserted-by":"crossref","unstructured":"Behera SK, Vhora N, Contractor D, Shard A, Kumar D, Kalia K et al. Computational drug repurposing study elucidating simultaneous Inhibition of entry and replication of novel Corona virus by Grazoprevir. Sci Rep. 2021;11.","DOI":"10.1038\/s41598-021-86712-2"},{"key":"2011_CR47","doi-asserted-by":"crossref","unstructured":"Zhang Y, Huo M, Zhou J, Zou A, Li W, Yao C et al. DDSolver: An Add-In Program for Modeling and Comparison of Drug Dissolution Profiles. AAPS J. 2010;12:263. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2895453\/","DOI":"10.1208\/s12248-010-9185-1"},{"key":"2011_CR48","unstructured":"Council NR. Guide for the Care and Use of Laboratory Animals: Eighth Edition. Guide for the Care and Use of Laboratory Animals. 2010."},{"key":"2011_CR49","unstructured":"OECD. Test No. 405: Acute Eye Irritation\/Corrosion, OECD Guidelines for the Testing of Chemicals. OECD Publishing, Paris. 2023;Sect.\u00a04. Available from: https:\/\/www.oecd.org\/en\/publications\/test-no-405-acute-eye-irritation-corrosion_9789264185333-en.html"},{"key":"2011_CR50","unstructured":"United States Pharmacopeia. General Chapter, \u3008771\u3009 Ophthalmic Products\u2014Quality Tests. 2024. Available from: https:\/\/doi.usp.org\/USPNF\/USPNF_M99560_06_01.html"},{"key":"2011_CR51","unstructured":"United States Pharmacopeia. General Chapters: <1151\u2009>\u2009Pharmaceutical dosage Forms - Ophthalmic preparations. 2024. Available from: http:\/\/www.pharmacopeia.cn\/v29240\/usp29nf24s0_c1151s44.html"},{"key":"2011_CR52","doi-asserted-by":"crossref","unstructured":"Hollingsworth SA, Dror RO. Molecular Dynamics Simulation for All. Neuron. 2018;99:1129\u201343. Available from: https:\/\/www.cell.com\/action\/showFullText?pii=S0896627318306846","DOI":"10.1016\/j.neuron.2018.08.011"},{"key":"2011_CR53","doi-asserted-by":"publisher","unstructured":"Li Y, Pang H, Guo Z, Lin L, Dong Y, Li G et al. Interactions between drugs and polymers influencing hot melt extrusion. Journal of Pharmacy and Pharmacology. 2014;66:148\u201366. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/https:\/\/doi.org\/10.1111\/jphp.12183","DOI":"10.1111\/jphp.12183"},{"key":"2011_CR54","doi-asserted-by":"crossref","unstructured":"Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. Journal of Controlled Release. 1987;5:37\u201342. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/0168365987900356","DOI":"10.1016\/0168-3659(87)90035-6"},{"key":"2011_CR55","unstructured":"Perold Z. The polymorphic and pseudopolymorphic behaviour of gatifloxacin crystal modifications. 2006. Available from: https:\/\/repository.nwu.ac.za\/handle\/10394\/1420"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-02011-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-02011-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-02011-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T14:51:14Z","timestamp":1772549474000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-02011-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2011"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-02011-7","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experimental protocol (LMCP\/IAEC\/2024\/5\/158) received approval from the Institutional Animal Ethics Committee (IAEC) of L.M. College of Pharmacy, India, and all animal studies were conducted in accordance with the guidelines laid down by the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Government of India.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We, the authors, give our full consent for the publication of our manuscript titled \u201cDevelopment, In silico, In vitro, and In vivo Evaluation of Gatiserts: HME-Based Ophthalmic Inserts for Prolonged Ocular Delivery of Gatifloxacin\u201d in Drug Delivery and Translational Research, confirming that we have contributed to the work, reviewed the final version, and agreed to its submission. We affirm that the manuscript is original, free of conflicts, and complies with ethical and copyright requirements.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or nonfinancial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}